SCHLEIFER LEONARD S 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed May 17, 2024
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2024-05-17$979.22/sh−22,687$22,215,564→ 467,020 total - Sale
Common Stock
2024-05-17$980.07/sh−143$140,150→ 466,877 total
Holdings
- 5,932(indirect: By 401(k))
Common Stock
- 64,985(indirect: By Trust)
Common Stock
- 157,552(indirect: 2023 GRAT)
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F2]Represents volume-weighted average price of sales of 22,687 shares of Company stock on May 17, 2024 at prices ranging from $979.00 to $979.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 143 shares of Company stock on May 17, 2024 at prices ranging from $980.01 to $980.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2024 at each separate price.